1. Home
  2. BRC vs CNTA Comparison

BRC vs CNTA Comparison

Compare BRC & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brady Corporation

BRC

Brady Corporation

HOLD

Current Price

$83.31

Market Cap

4.1B

ML Signal

HOLD

Logo Centessa Pharmaceuticals plc

CNTA

Centessa Pharmaceuticals plc

HOLD

Current Price

$39.64

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRC
CNTA
Founded
1914
2020
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
3.5B
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
BRC
CNTA
Price
$83.31
$39.64
Analyst Decision
Hold
Buy
Analyst Count
1
9
Target Price
$1.20
$42.00
AVG Volume (30 Days)
170.4K
4.2M
Earning Date
05-15-2026
05-13-2026
Dividend Yield
1.17%
N/A
EPS Growth
N/A
29.13
EPS
N/A
N/A
Revenue
$1,144,698,000.00
$15,000,000.00
Revenue This Year
$7.36
N/A
Revenue Next Year
$3.57
N/A
P/E Ratio
$23.35
N/A
Revenue Growth
5.86
N/A
52 Week Low
$65.76
$10.95
52 Week High
$99.29
$40.26

Technical Indicators

Market Signals
Indicator
BRC
CNTA
Relative Strength Index (RSI) 47.61 76.90
Support Level $76.10 $24.80
Resistance Level $86.37 $40.26
Average True Range (ATR) 2.21 1.07
MACD 0.40 0.80
Stochastic Oscillator 73.80 96.49

Price Performance

Historical Comparison
BRC
CNTA

About BRC Brady Corporation

Brady Corp provides identification solutions and workplace safety products. The company offers identification and healthcare products that are sold under the Brady brand to maintenance, repair, and operations as well as original equipment manufacturing customers. Products include safety signs and labeling systems, material identification systems, wire identification, patient identification, and people identification. Brady also provides workplace safety and compliance products such as safety and compliance signs, asset tracking labels, and first-aid products. The company is organized and managed on a geographic basis with two reportable segments: Americas & Asia which derives maximum revenue, and Europe & Australia.

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

Share on Social Networks: